 Experience as an entrepreneur, on a food and beverage delivery company, 19 employees and sales at USD 500K/year.

 Responsible for the management of the brand Tygacil in Brazil, with full alignment of marketing strategies with the region, with focus on hospital channel. Lead the implementation of the product’s commercial policy, approval of the commercial discount, supply process and expiration dates of the products. Speakers’ development and training. Lifecycle management of the brand.

➢ Responsible for the management of Actemra and MabTera, immunobiologicals for rheumatoid arthritis in a highly complex market. Leading products at 45% CAGR.➢ Member of Actemra IBT (International Brand Team) participating in discussions and definition of global brand strategies.➢ Lead access to private and public markets, setting strategy, roles, and responsibilities along with access area.➢ Management of patient support program and development and implementation ofpersonalized medicine project➢ Development and implementation of strategies awarded by the global team and disseminatedto other affiliates.➢ Management of the business strategy, assessment of the key business indicators, periodicalbusiness reviews with local, regional, and global teams, evaluating potential upsides anddownsides.➢ Work closely with KOLs in the development and shaping of the treatment guidelines ensuringfavorable reimbursement.➢ Work close with sales operations, make recommendations to maximize sales and sales forceeffectiveness, CRM implementation as well as targeting and segmentation.

 Leading a team of 13 people. Pipeline strategic management and planning. Implementation of Business Intelligence system and sales force automation as well as a new model of variable compensation for sales force. Identification of talents, elaboration of the succession plans, implementation of job rotation program for marketing conducted based on coaching, mentoring and counseling. Interface with actual and future international partners managing license-in and license-out products. Enhancement of sales force effectiveness through new parameters of segmentation, KPI's definition and promotional structure. Sales force engagement through discussion of strategies and tactics to incorporate their insights on marketing plans. Introduction of a management tool for events area achieving 15% reduction on travel costs.

 Pipeline strategic management as well as market and financial viability analysis. Marketing plans development: promotional mix, product positioning, pricing, forecast, brand character and launching campaign. Relationship with medical societies and key opinion leaders. B2B prospecting and negotiations (license-in e license-out). Maintenance of sales volume of company 2nd brand due to strategy fostered when generic competition achieve the market (accumulating product manager function).

 Active participation of company start-up in Brazil as well as organizational processes. Establishment of oncology sales consultant team, leading the process for defining its size, products to be promoted, targeting and visitation strategies, fixed and variable compensation, and KPIs. Oncology business unit budget management. Development of marketing plans and oncology portfolio launching. Relationship with medical societies and key opinion leaders. Generics and branded generics new business units planning, along with B2B prospecting.

 Gemzar marketing plan, budget management, promotional campaigns, continued medical education program. Pre-marketing and launch planning of Alimta liaising with the Global Brand Team. Relationship with medical societies, key opinion leaders and major buyers. Development of real demand project for oncology business unit. Acting along with clinical research area on the strategic decision making process to evaluate studies to be conducted in Brazil. Acting along with training department supporting courses and defining its programs. Organization and coordination of national and international events.